Allergan Finds White Knight In $66B Actavis Takeover
By Karlee Weinmann ( November 17, 2014, 10:03 AM EST) -- Allergan Inc. said Monday it would sell itself to rival drugmaker Actavis PLC for roughly $66 billion to thwart the long-running $55 billion hostile buyout campaign launched by Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.